📊 Score Breakdown
Offering Ability
100
Cash Runway
65
Float Risk
35
Warrant Exposure
30
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
44%
💰 Capital Raise
53%
• Under 12 months cash (8mo)
• Active shelf registration ($400M, 183% of market cap)
📉 Score Deterioration
50%
• Score rose 50 points recently (worsening)
• Score in HIGH risk zone (71/100)
📜 Warrant Exercise
15%
• Warrant overhang: 6.6% of shares outstanding
💹 Market Data
Market Cap$218.34M
Shares Outstanding19.09M
Float13.19M
Cash$14.95M
Debt$14.34M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 16.0% shares (2025Q4 vs prior)
40 institutional holders · 2.46M shares
#1
Knoll Capital Management, LLC
630.9K shares
#2
VANGUARD GROUP INC
496.9K shares
#3
Sio Capital Management, LLC
296.9K shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest1.74M
Days to Cover12.2
% of Float13.2%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Dec 31, 2025
xbrl
XBRL CONVERTIBLE
Dec 31, 2025
424B5
ATM
Mar 16, 2026
8-K
8K EVENT
Mar 16, 2026
EFFECT
EFFECT
Mar 16, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for ELTX
📊 ELTX FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 ELTX Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.